Abstract
ASD misdiagnosis, late diagnosis, or wrong treatment can be easily recognized as the major medical problem on this disorder in México. The real incidence of autism spectrum disorders in Mexico is largely unknown, official estimates ranges about one to four per 1,000 inhabitants. ASD is one of the most common causes of neurological and/or genetic consultation, but the number of board-certified pediatric neurologists and geneticists is not sufficient since the number of cases is growing. The diagnosis is still made around 4 years when the child starts school and teachers noticed their abnormal behavior and usually is referred to a psychologist attention. At this moment the evaluation by the pediatric neurologist is the most accurate way to have the proper diagnosis and guidance to obtain the best treatment. Today in Mexico there is a growing problem with alternative therapies since an increased number of parents choose “stem cell” injections, which by now have only shown to be more dangerous than successful. Parents still have a rejection about genetic testing, since the studies are expensive and most of cases do not change the treatment; the problem is more complex; the fear of having information of a hereditary disorder in the family is very noticeable and independent of educational or economical resources.
The use of standard tools to diagnose and treat autism in México has been growing, as professionals’ knowledge goes actualized by several means. The national programs created by several nongovernmental associations to early detection of autism are growing. Also, diverse kinds of facilities are creating all over the country to cover the ASD person’s needs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Albores L, Hernández L, Díaz JA, Cortés B. Dificultades en la evaluación y diagnóstico del autismo: una discusión. Salud Ment. 2008;31:37–44.
Albores L, Roldán O, Villarreal G, Betanzos BX, Santos C, Martínez-Jaime MM, et al. M-CHAT Mexican version validity and reliability and some cultural considerations. ISRN Neurol. 2012; 2012: 408694. doi: 10.5402/2012/408694. Epub 2012 Jul 1.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text edition. Washington, DC: American Psychiatric Association; 2000.
Anagnostou E, Hansen R. Medical treatment overview: traditional and novel psycho- pharmacological and complementary and alternative medications. Curr Opin Pediatr. 2011;23:621–7.
Bauman ML. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics. 2010;7:320–7.
Benvenuto A, Battan B, Porfirio MC, Curatolo P. Pharmacotherapy of autism spectrum disorders. Brain Dev. 2012; Apr 25. [Epub ahead of print].
Bravo A, Vázquez J, Cuello CA, Calderón RF, Hernández AM, Esmer C. Manifestaciones iniciales de los trastornos del espectro autista. Experiencia en 393 casos atendidos en un centro neurológico infantil. Neurología. 2012; 27:414–20.
Caglayan AO. Genetic causes of syndromic and non-syndromic autism. Dev Med Child Neurol. 2010;52:130–8.
Campos V, Morales R, López M, Torres KD, Bravo A. Uso de flunarizina en un caso con síndrome de Landau-Kleffner. Bol Med Hosp Infant Mex. 2011;68:48–53.
Cebula KR. Applied behavior analysis programs for autism: sibling psychosocial adjustment during and following intervention use. J Autism Dev Disord. 2012;42:847–62.
Coolican J, Smith IM, Bryson SE. Brief parent training in pivotal response treatment for preschoolers with autism. J Child Psychol Psychiatry. 2010;51:1321–30.
Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125:e17–23.
Esmer C, Salazar A, Hernández H, Bravo A. Insomnio y anormalidades conductuales como manifestaciones iniciales en una paciente con síndrome de Sanfilippo. Acta Ped Mex. 2011;32:15–21.
Flippin M, Reszka S, Watson LR. Effectiveness of the Picture Exchange Communication System (PECS) on communication and speech for children with autism spectrum disorders: a meta-analysis. Am J Speech Lang Pathol. 2010;19:178–95.
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591–8.
Fombonne E, Marcin C, Bruno R, Tinoco CM, Marquez CD. Screening for autism in Mexico. Autism Res. 2012;5:180–9.
Howlin P, Magiati I, Charman T. Systematic review of early intensive behavioral interventions for children with autism. Am J Intellect Dev Disabil. 2009;114:23–41.
Jeste SS. The neurology of autism spectrum disorders. Curr Opin Neurol. 2011;24:132–9.
Lafasakis M, Sturmey P. Training parent implementation of discrete-trial teaching: effects non generalization of parent teaching and child correct responding. J Appl Behav Anal. 2007;40:685–9.
Levy SE, Mandell DS, Schultz RT. Autism Lancet. 2009;374:1627–38.
López Ornat S, Gallo P. Acquisition, learning, or development of language? Skinner’s “Verbal Behavior” revisited. Span J Psychol. 2004;7:161–70.
Mesibov GB, Shea V. The TEACCH program in the era of evidence based practice. J Autism Dev Disord. 2010;40:570–9.
Miles JH. Autism spectrum disorders: a genetics review. Genet Med. 2011;13:278–94.
Mintz M et al. Treatment approaches for the autism spectrum disorders. In: Tuchman R, Rapin I, editors. Autism: a neurological disorder of early brain development. International child neurology association. United Kigdom: McKeith Press; 2006. p. 281–307.
Mottron L. Matching strategies in cognitive research with individuals with high functioning autism: current practices, instrument biases, and recommendations. J Autism Dev Disord. 2004;34:19–27.
Nicholas JS, Charles J, Carpenter LA, King LB, Jenner W, Spratt EG. Prevalence and characteristics of children with autism spectrum disorders. Ann Epidemiol. 2008;18:130–6.
Ozonoff S, Iosif AM, Baguio BS, Cook IC, Moore-Hill M, Hutman T, Rogers SJ, Rozga A, Sangha S, Sigman M, Steinfeld MB, Young GS. Prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256–66.
Pedersen A, Pettygrove S, Meaney FJ, Mancilla K, Gotschal K, Kessler DB, et al. Prevalence of autism spectrum disorders in Hispanic and non-Hispanic white children. Pediatrics. 2012;129:e629–35.
Rossignol DA. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009;21:213–36.
Sánchez A, Martínez L, Arteaga G, Torres R, Marroquín AR, Abrego V, et al. Secuelas neurológicas en tres pacientes con fenilcetonuria clásica diagnosticada tardíamente. Bol Med Hosp Infant Mex. 2008;65:191–5.
Sharma A, Shaw SR. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis. J Pediatr Health Care. 2012;26:291–9.
Tuman JP, Roth D, Lee D, Vecchio J. Autism and special education policy in Mexico. Global Health Governance. 2008; 2(1). blogs.shu.edu/ghg/2008/04/01/autism-and-special education-policy-in-mexico/.
Veness C, Prior MR, Bavin E, Eadie P, Cini E, Reilly S. Early indicators of autism spectrum disorders at 12 and 24 months of age: A prospective, longitudinal comparative study. Autism. 2012;16:163–77.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Oro, A.B., Esmer, C., Navarro-Calvillo, M.E. (2014). Autism Spectrum Disorders in Mexico. In: Patel, V., Preedy, V., Martin, C. (eds) Comprehensive Guide to Autism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4788-7_162
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4788-7_162
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4787-0
Online ISBN: 978-1-4614-4788-7
eBook Packages: Behavioral Science